Back
Altimmune Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
63
ALT
Altimmune
Last Price:
8.04
Seasonality Move:
25.96%
Sell
30
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-0.57%
Buy
63
Altimmune (ALT)
is a Buy
Is Altimmune a Buy, Sell or Hold?
- The current Altimmune [ALT] share price is $8.05. The Score for ALT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- ALT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALT Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
ALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 55.76 | Buy |
| Chaikin Money Flow: | 841796 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.57 - 8.11) | Buy |
| Bollinger Bands (100): | (6.18 - 7.54) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 53 | Buy |
| Chaikin Money Flow: | 9133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.75) | Buy |
| Bollinger Bands (100): | (0.28 - 1.48) | Sell |
ALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.14 | Sell |
| 20-day SMA: | 7.47 | Buy |
| 50-day SMA: | 7.07 | Buy |
| 200-day SMA: | 7.61 | Buy |
| 8-day EMA: | 7.84 | Buy |
| 20-day EMA: | 7.57 | Buy |
| 50-day EMA: | 7.18 | Buy |
| 200-day EMA: | 7.09 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Sell |
| 20-day SMA: | 0.7 | Buy |
| 50-day SMA: | 0.65 | Buy |
| 200-day SMA: | 2.37 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.7 | Buy |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 5.67 | Sell |
Altimmune Earnings Growth & ALT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.23 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Altimmune Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||